Judge grants Amarin's request

A federal judge granted Amarin Corp.'s (Nasdaq: AMRN) request for a summary judgment in the biopharmaceutical's suit seeking Food and Drug Administration recognition of a five-year marketing exclusivity for Vascepa. The stock price climbed 37 cents to close at $2.32.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.